FLR
55
6
ESS
64
4
DRI
48
3
AFL
49
3
V
66
6
AIG
44
6
DTE
54
4
GIS
28
2
EXPE
91
3
HST
58
18
VNO
50
-9
CAH
53
6
CRM
65
6
TROW
51
3
GOOGL
45
-9
JNJ
44
3
DGX
50
2
PNR
69
4
F
47
4
DE
56
10
FLR
55
6
ESS
64
4
DRI
48
3
AFL
49
3
V
66
6
AIG
44
6
DTE
54
4
GIS
28
2
EXPE
91
3
HST
58
18
VNO
50
-9
CAH
53
6
CRM
65
6
TROW
51
3
GOOGL
45
-9
JNJ
44
3
DGX
50
2
PNR
69
4
F
47
4
DE
56
10
Financhill
Back

Mithra Pharmaceuticals SA Vs. UCB SA Industry Stock Comparison

Sell
35

MITPF
Mithra Pharmaceuticals SA

Last Price:
6.75
Seasonality Move:
7.52%
Sell
46

UCBJY
UCB SA

Last Price:
93.66
Seasonality Move:
4.8%
Sell
35
Mithra Pharmaceuticals SA (MITPF) is a Sell

Is Mithra Pharmaceuticals SA a Buy, Sell or Hold?

  • The current Mithra Pharmaceuticals SA [MITPF] share price is $6.75. The Score for MITPF is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • MITPF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
UCB SA (UCBJY) is a Sell

Is UCB SA a Buy, Sell or Hold?

  • The current UCB SA [UCBJY] share price is $91.17. The Score for UCBJY is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • UCBJY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MITPF Stock Price Chart

What is Mithra Pharmaceuticals SA's stock price today?

UCBJY Stock Price Chart

What is UCB SA's stock price today?

  • The UCB SA share price today is $91.17
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UCBJY is experiencing slight buying pressure.

MITPF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Sell
Relative Strength Index (14 RSI): 0 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.75 - 6.75) Sell
Bollinger Bands (100): (6.75 - 6.75) Sell

UCBJY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.11 Sell
Relative Strength Index (14 RSI): 43.86 Sell
Chaikin Money Flow: 3088 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.27 - 98.33) Sell
Bollinger Bands (100): (82.04 - 94.72) Buy

MITPF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.75 Sell
20-day SMA: 6.75 Sell
50-day SMA: 6.75 Sell
200-day SMA: 6.75 Sell
8-day EMA: 6.75 Sell
20-day EMA: 6.75 Sell
50-day EMA: 6.75 Sell
200-day EMA: 6.85 Sell

UCBJY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.22 Sell
20-day SMA: 94.98 Sell
50-day SMA: 93.12 Sell
200-day SMA: 75.92 Buy
8-day EMA: 91.22 Sell
20-day EMA: 93.2 Sell
50-day EMA: 92.28 Sell
200-day EMA: 77.8 Buy

Mithra Pharmaceuticals SA Earnings Growth & MITPF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

UCB SA Earnings Growth & UCBJY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Mithra Pharmaceuticals SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

UCB SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):